Core Viewpoint - The announcement details the share pledge situation of the controlling shareholder, Liang Yaoming, and the associated risks for the company and its investors [1][2]. Group 1: Share Pledge Details - The controlling shareholder, Liang Yaoming, directly holds 74,191,907 shares, accounting for 16.02% of the total share capital. The pledged shares amount to 6,500,000, which is 8.76% of his directly held shares and 1.40% of the total share capital [1]. - After the pledge, the total shares pledged by Liang Yaoming and his associates, including Yan Ting and Zeng Zhanwen, as well as entities controlled by him, amounts to 38,080,000 shares, representing 23.08% of his total holdings and 8.22% of the total share capital [1][2]. - The pledged shares are not used as collateral for major asset restructuring or performance compensation [1]. Group 2: Monitoring and Disclosure - The company will closely monitor the developments related to the share pledges and will disclose relevant information in a timely manner according to regulations [2].
广州金域医学检验集团股份有限公司 关于控股股东、实际控制人部分股份质押的公告